Article Information
History
- November 18, 2018.
Article Versions
- You are currently viewing Version 1 of this article (November 18, 2018 - 16:11).
- Version 2 (November 21, 2018 - 11:03).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Stefan Sieber1,
- Annika Winter2,
- Johanna Wachsmuth1,
- Rhiannon David5,
- Maria Stecklum3,
- Lars Hellmeyer4,
- Lorna Ewart5,
- Uwe Marx3,
- Roland Lauster1 and
- Mark Rosowski1,*
- 1Technische Universität Berlin, Institute of Biotechnology, Department Medical Biotechnology, Gustav-Meyer-Allee 25, Berlin, DE
- 2TissUse GmbH, Oudenarder Str. 16, Berlin, DE
- 3EPO Experimentelle Pharmakologie & Onkologie Berlin-Buch GmbH, Robert-Rössle-Straße, 10, Berlin, DE
- 4Vivantes Klinikum im Friedrichshain, Landsberger Allee 49, Berlin, DE
- 5AstraZeneca, Cambridge, UK
- ↵*corresponding author
Posted November 18, 2018.
